Scientific analyzes results of cerebrospinal fluid in patients with transverse myelitis. FDA’s RDEP in Context Developing treatments for ultra-rare diseases…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.
